What is RehaBrix

RehaBrix: Revolutionizing Stroke Recovery with Innovation

Rehabrix recognises that key challenges that stroke survivors face are a lengthly recovery process and a costly journey. This shaped Rehabrixs primary objecitve - to optimise the rehabitlitaiton journey and enhance patient outcomes. 

RehaBrix is a cutting-edge injectable therapy designed to enhance muscle recovery in patients with stroke-induced muscle atrophy. Engineered with biodegradable hydrogel and growth factors encapsulated in PLGA microparticles, RehaBrix aims to deliver the growth factors with a triphasic release mechanism, ensuring a sustained and controlled delivery of the therapeutic agents. The formulation supports muscle regeneration, accelerates recovery, and improves functional outcomes with minimal toxicity. Unlike traditional treatments that require frequent dosing, RehaBrix offers long-term efficacy with just one injection every three months, reducing treatment burdens while promoting greater patient compliance and healthcare efficiency. 

With RehaBrix, our mission is to redefine stroke rehabilitation by providing a targeted, long-lasting therapy that works alongside traditional treatments to enhance recovery, reduce rehabilitation burdens, and improve patient outcomes.